AiVita Biomedical

AiVita Biomedical

AiVita Biomedical

AiVita Biomedical is is a medicine company, develops commercial and clinical stage programs utilizing curative and regenerative medicines.
Type
B2c
Founded
2016
Raised
$31.2M
Follow us
Alexa global traffic share
Latest funding Show all
$12,500,000
Venture capital (Series B) - 2020
Matthew Katz
$1,700,000
Grant - 2018
The California Institute for Regenerative Medicine (CIRM)
Team Size
10+
Employees
$12,500,000 Venture capital (Series B)
FinSMEs

Aivita Biomedical Raises $12.5M in Series B-2 Financing

$1,700,000 Grant
FinSMEs

Aivita Biomedical Receives $1.7M Grant to Treat Vision Loss

Health
$15,000,000 Venture capital (Series B)
FinSMEs

Aivita Biomedical Raises $15M in Series B Financing

Health Funding
$2,000,000 Venture capital (Series A)
FinSMEs

Therapeutic Development Company AiVita Biomedical Completes $2M Series A Funding

Funding Health